Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrothorax | 4 | 2023 | 5 | 2.990 |
Why?
|
| Liver Cirrhosis | 7 | 2023 | 184 | 1.800 |
Why?
|
| Liver Transplantation | 2 | 2023 | 222 | 1.310 |
Why?
|
| Hepatic Encephalopathy | 2 | 2023 | 10 | 0.870 |
Why?
|
| Hypertension, Portal | 2 | 2022 | 19 | 0.840 |
Why?
|
| Empyema | 1 | 2022 | 5 | 0.730 |
Why?
|
| Probiotics | 2 | 2015 | 57 | 0.550 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 94 | 0.420 |
Why?
|
| Retrospective Studies | 5 | 2023 | 6955 | 0.360 |
Why?
|
| Pancreatic Elastase | 1 | 2012 | 32 | 0.360 |
Why?
|
| Serum | 1 | 2012 | 27 | 0.360 |
Why?
|
| Hepatitis C | 1 | 2013 | 145 | 0.350 |
Why?
|
| Stents | 1 | 2015 | 501 | 0.340 |
Why?
|
| Hospital Mortality | 1 | 2015 | 881 | 0.330 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2012 | 70 | 0.320 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 922 | 0.280 |
Why?
|
| Leptin | 1 | 2006 | 89 | 0.240 |
Why?
|
| Hepatocytes | 2 | 2006 | 226 | 0.230 |
Why?
|
| Liver | 2 | 2006 | 875 | 0.220 |
Why?
|
| Apoptosis | 2 | 2006 | 1100 | 0.210 |
Why?
|
| Ascites | 1 | 2022 | 22 | 0.180 |
Why?
|
| Humans | 10 | 2023 | 65837 | 0.180 |
Why?
|
| Tertiary Care Centers | 1 | 2022 | 111 | 0.170 |
Why?
|
| Adult | 4 | 2023 | 17575 | 0.150 |
Why?
|
| Prognosis | 1 | 2023 | 1794 | 0.140 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 10 | 0.120 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 11 | 0.120 |
Why?
|
| Permeability | 1 | 2015 | 52 | 0.110 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2015 | 17 | 0.110 |
Why?
|
| Diarrhea | 1 | 2015 | 75 | 0.110 |
Why?
|
| Liver Diseases | 1 | 2015 | 157 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 183 | 0.100 |
Why?
|
| Intestines | 1 | 2015 | 184 | 0.100 |
Why?
|
| Coronary Artery Bypass | 1 | 2015 | 292 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 254 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2023 | 5834 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2015 | 888 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2015 | 273 | 0.080 |
Why?
|
| Male | 4 | 2015 | 31406 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 710 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2015 | 2651 | 0.070 |
Why?
|
| Aged | 3 | 2015 | 15146 | 0.070 |
Why?
|
| Female | 4 | 2015 | 34423 | 0.070 |
Why?
|
| Quinazolines | 1 | 2007 | 21 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2007 | 25 | 0.060 |
Why?
|
| Obesity | 1 | 2015 | 1281 | 0.060 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 15 | 0.060 |
Why?
|
| Thioacetamide | 1 | 2006 | 5 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 40 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2012 | 631 | 0.060 |
Why?
|
| Middle Aged | 2 | 2015 | 18498 | 0.060 |
Why?
|
| Egg Proteins | 1 | 2006 | 24 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2007 | 198 | 0.060 |
Why?
|
| Ovalbumin | 1 | 2006 | 108 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 195 | 0.060 |
Why?
|
| Actins | 1 | 2006 | 265 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 432 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2006 | 3506 | 0.040 |
Why?
|
| United States | 1 | 2015 | 8189 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2006 | 679 | 0.040 |
Why?
|
| Mice | 2 | 2006 | 11185 | 0.030 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2015 | 33 | 0.030 |
Why?
|
| Animals | 2 | 2006 | 21493 | 0.020 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 19 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2007 | 128 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2007 | 371 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2006 | 42 | 0.010 |
Why?
|
| Child | 1 | 2015 | 4651 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 145 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 169 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 186 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 414 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 309 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 664 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2006 | 419 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 755 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1292 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 712 | 0.010 |
Why?
|